Market revenue in 2023 | USD 3.4 million |
Market revenue in 2030 | USD 11.5 million |
Growth rate | 18.8% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, NGS Commercial Software |
Key market players worldwide | Bio-Rad Laboratories Inc, DNAnexus, Qiagen NV, DNAstar, Pacific Biosciences of California Inc, Eurofins Scientific SE, Illumina Inc, PierianDx, Agilent Technologies Inc, Roche Holding AG, Alphabet Inc Class A, Thermo Fisher Scientific Inc, Golden Helix, Scigenom Labs, Genuity Science, Fabric Genomics (formerly Omicia), Congenica, Precigen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to next-generation sequencing data analysis market will help companies and investors design strategic landscapes.
Services was the largest segment with a revenue share of 55.88% in 2023. Horizon Databook has segmented the South Africa next-generation sequencing data analysis market based on services, ngs commercial software covering the revenue growth of each sub-segment from 2018 to 2030.
In South Africa, the prevalence of infectious as well as chronic diseases is extremely high, which increases the demand for NGS technologies in the country. The South African National Bioinformatics Institute (SANBI), which operates under the University of Western Cape, is engaged in the development of high-throughput genomics methods, including NGS, to study communicable diseases and other healthcare problems.
In addition, there are organizations such as the Well come Trust Africa that are working toward developing better NGS analysis and data storage for biomedical health research in the country. These initiatives, along with improved government funding and collaborations between global players & medical research institutes, are expected to drive the revenue in this regional market.
The emergence of COVID-19 also played a vital role in adoption of genome sequencing platforms. During the pandemic, SARS-CoV-2 genome was sequenced in laboratories of South Africa. In June 2020, COVID Network for Genomics Surveillance South Africa was established in the country to consolidate tracking of coronavirus.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa next-generation sequencing data analysis market , including forecasts for subscribers. This country databook contains high-level insights into South Africa next-generation sequencing data analysis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account